[{"Assets_0_Q3_USD":155888000.0,"CommonStockSharesOutstanding_0_Q3_shares":37450000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-30072000.0,"NetIncomeLoss_1_Q3_USD":-8864000.0,"NetIncomeLoss_3_Q3_USD":-30487000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":37436000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":37382000.0,"StockholdersEquity_0_Q3_USD":-26963000.0,"EarningsPerShareBasic_1_Q3_USD":-0.24,"EarningsPerShareBasic_3_Q3_USD":-0.82,"Ticker":"AVDL","CIK":"1012477","name":"AVADEL PHARMACEUTICALS PLC","OfficialName":"Avadel Pharmaceuticals plc American Depositary Shares","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"391383731.0","Country":"France","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191112"}]